US Allows Increased Production of ADHD Drug Vyvanse

Published on September 5, 2024

The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues. Following a request from the U.S. Food and Drug Administration in July, the DEA said Thursday…

Read Full Article (External Site)